Electrocardiograph (ECG) Stress Test Market Report 2025

The electrocardiograph (ECG) test stress test market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $3.94 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to increasing awareness of preventive cardiac care, wider adoption of routine health screenings, higher healthcare expenditures in developed countries, growing demand for early detection of heart conditions, and increased use of exercise-based cardiac assessments.

The electrocardiograph (ECG) test stress test market size is expected to see strong growth in the next few years. It will grow to $5.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period can be attributed to the increasing adoption of portable and wearable electrocardiograph devices, rising demand for remote and home-based cardiac monitoring, heightened focus on early detection of cardiovascular disorders, growing preference for personalized cardiac care, and expanding government initiatives promoting heart disease screening. Key trends during this period include advancements in wearable ECG technologies, innovations in AI-powered ECG interpretation, integration of ECG systems with telemedicine platforms, improvements in portable stress testing devices, and developments in cloud-based ECG data storage and sharing.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the electrocardiograph (ECG) test market moving forward. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including heart attacks, strokes, and hypertension. The rise in these diseases is largely due to growing rates of high blood pressure, which increases strain on the heart and blood vessels, elevating the risk of heart attacks and strokes. An electrocardiograph (ECG) test assists in detecting cardiovascular issues by assessing how the heart performs under physical stress, uncovering hidden problems such as narrowed arteries, irregular heart rhythms, and reduced blood flow that might not be visible when the body is at rest. For example, in October 2024, the Centers for Disease Control and Prevention, a US government agency, reported that around 805,000 people in the United States suffer a heart attack each year; among these, 605,000 are first-time incidents, and 200,000 occur in people with previous heart attack history. Thus, the growing incidence of cardiovascular diseases is boosting the demand for electrocardiograph (ECG) tests.

Leading companies in the electrocardiograph (ECG) stress test market are concentrating on technological advancements such as cardiosoft technology to improve diagnostic precision, workflow efficiency, and integration within cardiology care systems. Cardiosoft technology is a PC-based ECG and stress testing system that enables physicians to monitor and analyze heart activity during rest or exercise, using software that facilitates easy data storage and review. For instance, in March 2025, GE HealthCare, a US health technology firm, introduced a cardiac assessment system designed for stress testing that helps clinicians quickly gain insights while ensuring smooth data flow - an important factor for cardiac patients. This system features advanced ECG analysis, stress testing functions, and seamless compatibility with electronic medical records for streamlined data management. It typically includes intuitive software with real-time monitoring, customizable reports, and automated measurement tools that aid in accurate diagnoses. Many such systems also offer wireless connectivity to allow mobility and adaptability in different clinical environments while ensuring high-quality signal capture and patient safety during cardiac evaluations.

In January 2023, CAIRE Inc., a US-based manufacturer of medical equipment, acquired MGC Diagnostics Holdings Inc. for an undisclosed sum. This acquisition aims to expand CAIRE Inc.’s global respiratory care portfolio by incorporating MGC Diagnostics’ non-invasive technologies, including ECG stress test systems. This move positions CAIRE Inc. to support the entire spectrum of pulmonary care, from early diagnosis to long-term oxygen therapy. MGC Diagnostics Holdings Inc. is a US company specializing in non-invasive cardiorespiratory diagnostic systems, which include electrocardiography stress test equipment.

Major players in the electrocardiograph (ECG) stress test market are Cardinal Health Inc., Koninklijke Philips N.V., GE HealthCare Technologies Inc., Baxter International Inc., Nihon Kohden Corporation, BTL Industries Inc., Fukuda Denshi Co Ltd., Neurosoft LLC, Schiller AG, Meditech Equipment Co Ltd., CAIRE Inc., COSMED Srl, MGC Diagnostics Corporation, Allengers Global Healthcare Pvt Ltd., EB Neuro S.p.A., custo med GmbH, Clarity Medical Technologies Pvt Ltd., Cortex Biophysik GmbH, Norav Medical Ltd., and Medset Medizintechnik GmbH.

North America was the largest region in the electrocardiograph (ECG) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in electrocardiograph (ECG) stress test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the electrocardiograph (ECG) stress test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The electrocardiograph (ECG) stress test market consists of revenues earned by entities by providing services such as treadmill stress electrocardiograph testing, pharmacologic stress electrocardiograph testing, stress echocardiography with electrocardiograph monitoring, ambulatory stress electrocardiograph monitoring, and pre- and post-stress rest electrocardiograph testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrocardiograph (ECG) stress test market also includes sales of treadmill stress test systems, stress echocardiography systems, wireless electrocardiograph monitoring systems, patch-based electrocardiograph devices, and cardiac stress test simulators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The electrocardiograph (ECG) stress test market research report is one of a series of new reports that provides main types of electrocardiograph (ECG) stress test market statistics, including main types of electrocardiograph (ECG) stress test industry global market size, regional shares, competitors with a main types of electrocardiograph (ECG) stress test market share, main types of electrocardiograph (ECG) stress test market segments, market trends and opportunities, and any further data you may need to thrive in the main types of electrocardiograph (ECG) stress test industry. This main type of electrocardiograph (ECG) stress test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An electrocardiograph (ECG) stress test is a diagnostic procedure that records the heart’s electrical activity both at rest and during physical or pharmacological stress. This test assesses how well the heart functions under these conditions, helping to detect irregular heart rhythms, blood flow problems, and signs of coronary artery disease by comparing ECG results from resting and stressed states.

The main types of ECG stress testing tools include standalone ECG devices, ECG test software, Holter monitors, event monitors, and portable ECG monitors. Standalone ECG devices operate independently without needing integration with other hospital systems and record and display the heart’s electrical signals for diagnostic use. The test types encompass exercise stress tests, pharmacological stress tests, and combined exercise and pharmacological stress tests. Various technologies involved include analog and digital ECG stress testing devices, cloud-based ECG solutions, wearable ECG monitors, and telemedicine-enabled ECG stress tests. These are utilized through multiple sales channels such as direct sales, distributors, online retailers, third-party resellers, and healthcare procurement organizations. The primary end users include hospitals, outpatient clinics, cardiology centers, home healthcare providers, and rehabilitation facilities.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.